These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


372 related items for PubMed ID: 29609578

  • 1. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location.
    Scotto di Carlo F, Divisato G, Iacoangeli M, Esposito T, Gianfrancesco F.
    BMC Cancer; 2018 Apr 02; 18(1):358. PubMed ID: 29609578
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Righi A, Mancini I, Gambarotti M, Picci P, Gamberi G, Marraccini C, Dei Tos AP, Simi L, Pinzani P, Franchi A.
    Hum Pathol; 2017 Oct 02; 68():128-135. PubMed ID: 28899740
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic Utility of Genetic and Immunohistochemical H3-3A Mutation Analysis in Giant Cell Tumour of Bone.
    Wągrodzki M, Tysarowski A, Seliga K, Wojnowska A, Stepaniuk M, Castañeda Wysocka P, Makuła D, Pieńkowski A, Szostakowski B, Zub R, Rutkowski P.
    Int J Mol Sci; 2022 Jan 16; 23(2):. PubMed ID: 35055156
    [Abstract] [Full Text] [Related]

  • 14. Detection of H3F3A p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR).
    Gamberi G, Morandi L, Benini S, Resca A, Cocchi S, Magagnoli G, Donati DM, Righi A, Gambarotti M.
    Pathol Res Pract; 2018 Jan 16; 214(1):89-94. PubMed ID: 29254795
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone.
    Yoshida KI, Nakano Y, Honda-Kitahara M, Wakai S, Motoi T, Ogura K, Sano N, Shibata T, Okuma T, Iwata S, Kawai A, Ichimura K, Yoshida A.
    Mod Pathol; 2019 Dec 16; 32(12):1751-1761. PubMed ID: 31285528
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors.
    Nohr E, Lee LH, Cates JM, Perizzolo M, Itani D.
    Hum Pathol; 2017 Oct 16; 68():119-127. PubMed ID: 28882701
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.